Latest News about MRK
Recent news which mentions MRK
Moderna Stock Is Soaring Today - Here's Why
December 14, 2023
From Benzinga
Pfizer's 2024 Outlook Disappointed Wall Street, But Where Will the Stock Be in 5 Years?
December 14, 2023
From Motley Fool
Dow Jones Skyrockets To Record Heights, Shatters 37,000 Mark, Fueled By Fed's Dovish Stance
December 13, 2023
From Benzinga
What's Going On With Moderna Stock Today?
December 12, 2023
From Benzinga
Why Is C4 Therapeutics (CCCC) Stock Up 72% Today?
December 12, 2023
From InvestorPlace
Why Is Cancer-Focused C4 Therapeutics Stock Soaring Today?
December 12, 2023
From Benzinga
Merck, Eisai Report Yet Another Failure For Keytruda Plus Lenvima Combo Trial, This Time In Endometrial Cancer
December 08, 2023
From Benzinga
5 Dividend Stocks That Recently Increased Their Payouts
December 06, 2023
From Motley Fool
From Benzinga
Merck Highlights Data On New Vaccine, Compares 'Tolerability And Safety' To Pfizer's
November 28, 2023
From Benzinga
Stability Seekers: 7 Low-Volatility Stocks for Uncertain Times
November 23, 2023
From InvestorPlace
Merck's Caraway Deal: Analyst Says "Timely, Anchored By Novel Programs & Management Team"
November 22, 2023
Tickers
MRK
From Benzinga
These ten stocks, not just from tech, are the key to next year’s S&P 500 earnings growth
November 21, 2023
From MarketWatch
Merck's Latest Drug For Chronic Cough Faces FDA Pushback
November 18, 2023
From Benzinga
FDA Approves Merck's Blockbuster Cancer Drug For Type Of Gastric Cancer
November 17, 2023
Tickers
MRK
From Benzinga
Bayer's Legal Victory Against Merck: Delaware Court Rules In Company's Favor Regarding Talc Lawsuits
November 17, 2023
From Benzinga
Senator's Bearish Tesla Bet Under Scrutiny As He Buys Put Options Ahead Of Elon Musk-Led Company's Q3 Results That Set Stock Slide In Motion
November 17, 2023
From Benzinga
Merck's Gefapixant Under FDA Lens: Advisory Committee To Discuss Chronic Cough Drug's Future
November 16, 2023
Tickers
MRK
From Benzinga
FDA Approves Bristol-Myers' Lung Cancer Drug Acquired Via $4B Turning Point Deal: Competes With Roche, Merck, AstraZeneca
November 16, 2023
From Benzinga
2 Healthcare Stocks That Could Make You Richer
November 15, 2023
From Motley Fool
The 3 Best Defensive Stocks for Uncertain Times
November 13, 2023
From InvestorPlace
Merck and Bristol Myers Squibb Will Face Off in This 1 Market -- but Who Will Win?
November 11, 2023
From Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
November 10, 2023
From Benzinga
WHO’s new COVID guidelines see fewer patients requiring hospitalization
November 10, 2023
From MarketWatch
Qualcomm, Merck And 2 Other Stocks Insiders Are Selling
November 10, 2023
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
